The biotech group has struggled as a whole in 2025, but analysts say the innovation that has always supported the biotech ...

Significant news coverage and COVID-19 flashbacks have driven investors into biotech stocks over the past week.

This biotech firm develops therapies for rare pulmonary diseases, leveraging proprietary drug delivery technology in the U.S.

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

On January 14, Reuters reported that investors foresee a comeback in the US biotech sector in 2026, with more IPO activity ...

Biotech M&A is surging ahead of a $300B patent cliff. Here are 3 gene-editing stocks investors are watching as potential acquisition targets ...

Smaller biotech stocks often fly under the radar. Many of them aren't consistently profitable, but some can deliver outsize ...

In 2025, biotechnology stocks had their best year since the COVID-19 pandemic, with the market sector’s two major indexes — the SDPR S&P Biotech ETX (NYSE: XBI) and iShares Biotech ETF (NYSE: IBB) — ...

Inhibrx Biosciences releases positive preliminary results from its trial of a new head and neck cancer treatment.

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up roughly 6% in Monday morning trading, changing hands near ...